Virtus KAR Health Sciences Inst HLHIX Fund Analysis

| Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis HLHIX

Will HLHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Increased confidence in Virtus KAR Health Sciences Inst's prospects relative to its Morningstar Category peers results in an upgrade in this strategy's Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center